A detailed history of Envestnet Asset Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 501,661 shares of EW stock, worth $35.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
501,661
Previous 1,152,390 56.47%
Holding current value
$35.7 Million
Previous $106 Million 68.9%
% of portfolio
0.01%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$59.7 - $93.78 $38.8 Million - $61 Million
-650,729 Reduced 56.47%
501,661 $33.1 Million
Q2 2024

Aug 08, 2024

SELL
$84.3 - $94.31 $2.71 Million - $3.04 Million
-32,185 Reduced 2.72%
1,152,390 $106 Million
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $4.1 Million - $5.41 Million
-56,567 Reduced 4.56%
1,184,575 $113 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $4.94 Million - $6.22 Million
80,025 Added 6.89%
1,241,142 $94.6 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $8.06 Million - $10.9 Million
116,275 Added 11.13%
1,161,117 $80.4 Million
Q2 2023

Aug 04, 2023

BUY
$81.41 - $94.33 $1.47 Million - $1.71 Million
18,114 Added 1.76%
1,044,842 $98.6 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $3.87 Million - $4.4 Million
52,072 Added 5.34%
1,026,728 $84.9 Million
Q4 2022

Feb 07, 2023

SELL
$68.3 - $87.44 $644,547 - $825,171
-9,437 Reduced 0.96%
974,656 $72.7 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $719,090 - $936,641
8,730 Added 0.9%
984,093 $81.3 Million
Q2 2022

Aug 03, 2022

SELL
$86.5 - $128.27 $55.9 Million - $82.9 Million
-646,060 Reduced 39.85%
975,363 $92.7 Million
Q1 2022

May 04, 2022

BUY
$101.96 - $128.34 $6.55 Million - $8.24 Million
64,224 Added 4.12%
1,621,423 $191 Million
Q4 2021

Feb 04, 2022

BUY
$106.37 - $130.68 $8.17 Million - $10 Million
76,817 Added 5.19%
1,557,199 $202 Million
Q3 2021

Oct 07, 2021

BUY
$102.91 - $122.75 $12.4 Million - $14.7 Million
120,051 Added 8.83%
1,480,382 $168 Million
Q2 2021

Aug 04, 2021

SELL
$83.84 - $104.76 $2.98 Million - $3.73 Million
-35,559 Reduced 2.55%
1,360,331 $141 Million
Q1 2021

May 04, 2021

BUY
$78.68 - $90.67 $14.3 Million - $16.4 Million
181,299 Added 14.93%
1,395,890 $117 Million
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $17.4 Million - $22.2 Million
243,191 Added 25.04%
1,214,591 $111 Million
Q3 2020

Oct 09, 2020

BUY
$67.19 - $87.44 $31.4 Million - $40.9 Million
468,044 Added 92.98%
971,400 $77.5 Million
Q2 2020

Jul 08, 2020

BUY
$57.54 - $76.95 $19.5 Million - $26 Million
338,470 Added 205.28%
503,356 $34.8 Million
Q1 2020

Apr 23, 2020

BUY
$52.41 - $81.0 $38,468 - $59,454
734 Added 0.45%
164,886 $31.1 Million
Q4 2019

Feb 11, 2020

BUY
$71.7 - $82.09 $150,856 - $172,717
2,104 Added 1.3%
164,152 $38.3 Million
Q3 2019

Oct 17, 2019

BUY
$61.55 - $75.43 $101,619 - $124,534
1,651 Added 1.03%
162,048 $35.6 Million
Q2 2019

Aug 02, 2019

BUY
$55.74 - $64.41 $664,142 - $767,445
11,915 Added 8.02%
160,397 $29.6 Million
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $367,124 - $491,007
-7,666 Reduced 4.91%
148,482 $28.4 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $5.95 Million - $7.3 Million
128,213 Added 458.97%
156,148 $23.9 Million
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $3.56 Million - $4.52 Million
-77,807 Reduced 73.58%
27,935 $4.86 Million
Q2 2018

Aug 10, 2018

BUY
$42.45 - $51.3 $467,501 - $564,966
11,013 Added 11.63%
105,742 $15.4 Million
Q1 2018

May 09, 2018

SELL
$37.19 - $47.45 $3.9 Million - $4.97 Million
-104,780 Reduced 52.52%
94,729 $13.2 Million
Q4 2017

Feb 20, 2018

BUY
$33.79 - $39.39 $740,980 - $863,783
21,929 Added 12.35%
199,509 $22.5 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $1.12 Million - $1.2 Million
30,803 Added 20.99%
177,580 $19.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
146,777
146,777 $17.4 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.